Search

Your search keyword '"Anastasia, Antonella"' showing total 215 results
Start Over Author "Anastasia, Antonella"
215 results on '"Anastasia, Antonella"'

1. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis

Author

Sacco, Antonio, Desantis, Vanessa, Celay, Jon, Giustini, Viviana, Rigali, Fabio, Savino, Francesco D., Cea, Michele, Soncini, Debora, Cagnetta, Antonia, Solimando, Antonio G., D’Aliberti, Deborah, Spinelli, Silvia, Ramazzotti, Daniele, Almici, Camillo, Todoerti, Katia, Neri, Antonino, Anastasia, Antonella, Tucci, Alessandra, Motta, Marina, Chiarini, Marco, Kawano, Yawara, Martinez-Climent, Jose A., Piazza, Rocco, and Roccaro, Aldo M.

Published
2023
Full Text
View/download PDF

2. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88

Author

Sacco, Antonio, Federico, Cinzia, Giacomini, Arianna, Caprio, Cinzia, Maccarinelli, Federica, Todoerti, Katia, Favasuli, Vanessa, Anastasia, Antonella, Motta, Marina, Russo, Domenico, Rossi, Giuseppe, Bozza, Nicole, Castelli, Riccardo, Neri, Antonino, Ronca, Roberto, Cattaneo, Chiara, Tucci, Alessandra, Mor, Marco, Presta, Marco, and Roccaro, Aldo M.

Published
2021
Full Text
View/download PDF

3. Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study.

Author

Bavieri, Alberto, Nizzoli, Maria E., Tucci, Alessandra, Zilioli, Vittorio R., Olivieri, Jacopo, Bianchi, Benedetta, Rosaria, Mansueto G., Annibali, Ombretta, Bari, Alessia, Casaluci, Gloria M., Cimminiello, Michele, Di Renzo, Nicola, Cavallo, Federica, Pavone, Vicenzo, Mannarella, Clara, Arcari, Annalisa, Alessandro, Maggi, Anastasia, Antonella, Tarantino, Vittoria, and Neri, Antonino

Published
2024
Full Text
View/download PDF

4. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

Author

Pagano, Livio, Criscuolo, Marianna, Broccoli, Alessandro, Piciocchi, Alfonso, Varettoni, Marzia, Galli, Eugenio, Anastasia, Antonella, Cantonetti, Maria, Trentin, Livio, Kovalchuk, Sofia, Orsucci, Lorella, Frustaci, Annamaria, Spolzino, Angelica, Volpetti, Stefano, Annibali, Ombretta, Storti, Sergio, Stelitano, Caterina, Marchesi, Francesco, Offidani, Massimo, Casadei, Beatrice, Nizzoli, Maria Elena, De Luca, Maria Lucia, Fianchi, Luana, Motta, Marina, Guarnera, Luca, Simonetti, Edoardo, Visentin, Andrea, Vassallo, Francesco, Deodato, Marina, Sarlo, Chiara, Olivieri, Attilio, Falini, Brunangelo, Pulsoni, Alessandro, Tiacci, Enrico, and Zinzani, Pier Luigi

Published
2022
Full Text
View/download PDF

5. Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review

Author

Criscuolo, Marianna, primary, Tosti, Maria Elena, additional, Broccoli, Alessandro, additional, Varettoni, Marzia, additional, Maraglino, Alessio Maria Edoardo, additional, Anastasia, Antonella, additional, Cantonetti, Maria, additional, Trentin, Livio, additional, Kovalchuk, Sofia, additional, Orsucci, Lorella, additional, Deodato, Marina, additional, Spolzino, Angelica, additional, Volpetti, Stefano, additional, Annibali, Ombretta, additional, Storti, Sergio, additional, Stelitano, Caterina, additional, Marchesi, Francesco, additional, Morè, Sonia, additional, Fianchi, Luana, additional, Falini, Brunangelo, additional, Pulsoni, Alessandro, additional, Tiacci, Enrico, additional, Zinzani, Pier Luigi, additional, and Pagano, Livio, additional

Published
2024
Full Text
View/download PDF

6. Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Author

Santoro, Armando, Mazza, Rita, Pulsoni, Alessandro, Re, Alessandro, Bonfichi, Maurizio, Zilioli, Vittorio Ruggero, Zanni, Manuela, Merli, Francesco, Anastasia, Antonella, Luminari, Stefano, Annechini, Giorgia, Gotti, Manuel, Peli, Annalisa, Liberati, Anna Marina, Di Renzo, Nicola, Castagna, Luca, Giordano, Laura, Ricci, Francesca, and Carlo-Stella, Carmelo

Published
2020
Full Text
View/download PDF

7. Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review

Author

Criscuolo, Marianna, Tosti, Maria Elena, Broccoli, Alessandro, Varettoni, Marzia, Maraglino, Alessio Maria Edoardo, Anastasia, Antonella, Cantonetti, Maria, Trentin, Livio, Kovalchuk, Sofia, Orsucci, Lorella, Deodato, Marina, Spolzino, Angelica, Volpetti, Stefano, Annibali, Ombretta, Storti, Sergio, Stelitano, Caterina, Marchesi, Francesco, Morè, Sonia, Fianchi, Luana, Falini, Brunangelo, Pulsoni, Alessandro, Tiacci, Enrico, Zinzani, Pier Luigi, Pagano, Livio, Storti, Sergio (ORCID:0000-0002-4374-3985), Pagano, Livio (ORCID:0000-0001-8287-928X), Criscuolo, Marianna, Tosti, Maria Elena, Broccoli, Alessandro, Varettoni, Marzia, Maraglino, Alessio Maria Edoardo, Anastasia, Antonella, Cantonetti, Maria, Trentin, Livio, Kovalchuk, Sofia, Orsucci, Lorella, Deodato, Marina, Spolzino, Angelica, Volpetti, Stefano, Annibali, Ombretta, Storti, Sergio, Stelitano, Caterina, Marchesi, Francesco, Morè, Sonia, Fianchi, Luana, Falini, Brunangelo, Pulsoni, Alessandro, Tiacci, Enrico, Zinzani, Pier Luigi, Pagano, Livio, Storti, Sergio (ORCID:0000-0002-4374-3985), and Pagano, Livio (ORCID:0000-0001-8287-928X)

Abstract

Concern has emerged about the prevalence of second cancers among patients with hairy cell leukemia (HCL) treated with purine analogs. We investigated 513 patients with HCL treated with cladribine over the last 30 years at 18 Italian centers and calculated their standardized incidence ratios (SIRs). We identified 24 patients with a second cancer diagnosed at a median time from treatment with cladribine of 59.9 months (range: 9.2-169.7 months). All patients with solid neoplasms presented with a limited-stage disease, except four cases of locally advanced cancer; multiple myeloma patients had a smoldering disease, while lymphoma patients had stage Ie and stage IV diseases. Response to therapy was complete in 19 cases; 1 patient is still receiving treatment for a relapsing bladder disease, while 2 patients progressed during treatment and died. These two patients died from unrelated causes: one from infection and one due to surgery complications. The median OS from HCL was 98.5 months (range: 38.4-409.2 months), while the median OS from second cancer was 27.6 months (range: 1-117.8 months). The SIR was 0.86 (95% CI: 0.54-1.30) for males and 1.13 (95% CI: 0.36-2.73) for females: no statistically significant differences were highlighted. We were not able to demonstrate an excess of second cancer or a significant association with the specific studied neoplasm.

Published
2024

10. Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis

Author

Sacco, A, Desantis, V, Celay, J, Giustini, V, Rigali, F, Savino, F, Cea, M, Soncini, D, Cagnetta, A, Solimando, A, D'Aliberti, D, Spinelli, S, Ramazzotti, D, Almici, C, Todoerti, K, Neri, A, Anastasia, A, Tucci, A, Motta, M, Chiarini, M, Kawano, Y, Martinez-Climent, J, Piazza, R, Roccaro, A, Sacco, Antonio, Desantis, Vanessa, Celay, Jon, Giustini, Viviana, Rigali, Fabio, Savino, Francesco D, Cea, Michele, Soncini, Debora, Cagnetta, Antonia, Solimando, Antonio Giovanni, D'Aliberti, Deborah, Spinelli, Silvia, Ramazzotti, Daniele, Almici, Camillo, Todoerti, Katia, Neri, Antonino, Anastasia, Antonella, Tucci, Alessandra, Motta, Marina, Chiarini, Marco, Kawano, Yawara, Martinez-Climent, Jose-Al, Piazza, Rocco, Roccaro, Aldo M, Sacco, A, Desantis, V, Celay, J, Giustini, V, Rigali, F, Savino, F, Cea, M, Soncini, D, Cagnetta, A, Solimando, A, D'Aliberti, D, Spinelli, S, Ramazzotti, D, Almici, C, Todoerti, K, Neri, A, Anastasia, A, Tucci, A, Motta, M, Chiarini, M, Kawano, Y, Martinez-Climent, J, Piazza, R, Roccaro, A, Sacco, Antonio, Desantis, Vanessa, Celay, Jon, Giustini, Viviana, Rigali, Fabio, Savino, Francesco D, Cea, Michele, Soncini, Debora, Cagnetta, Antonia, Solimando, Antonio Giovanni, D'Aliberti, Deborah, Spinelli, Silvia, Ramazzotti, Daniele, Almici, Camillo, Todoerti, Katia, Neri, Antonino, Anastasia, Antonella, Tucci, Alessandra, Motta, Marina, Chiarini, Marco, Kawano, Yawara, Martinez-Climent, Jose-Al, Piazza, Rocco, and Roccaro, Aldo M

Published
2023

11. Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Author

Luminari, Stefano, primary, Guerra, Luca, additional, Minoia, Carla, additional, Chauvie, Stephane, additional, Anastasia, Antonella, additional, Cavallo, Federica, additional, Corradini, Paolo, additional, Rattotti, Sara, additional, Durmo, Rexhep, additional, Ghiggi, Chiara, additional, Olivieri, Jacopo, additional, Ferrero, Simone, additional, Margiotta Casaluci, Gloria, additional, Nassi, Luca, additional, Stelitano, Caterina, additional, Ricci, Francesca, additional, Zilioli, Vittorio Ruggero, additional, Pinto, Antonio, additional, Zanni, Manuela, additional, Silvia, Bolis, additional, Patti, Caterina, additional, Merli, Michele, additional, Chiarenza, Annalisa, additional, Musuraca, Gerardo, additional, Tosi, Patrizia, additional, Federico, Massimo, additional, and Versari, Annibale, additional

Published
2022
Full Text
View/download PDF

13. Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial

Author

Ferreri, Andrés J.M., primary, Sassone, Marianna C., additional, Cangi, Maria Giulia, additional, Magliacane, Gilda, additional, Zanussi, Stefania, additional, Flospergher, Elena, additional, Marino, Fabrizio, additional, Bongiovanni, Lucia, additional, Ladetto, Marco, additional, Cavallo, Federica, additional, Aversa, Franco, additional, Anastasia, Antonella, additional, Mannina, Donato, additional, Pascarella, Anna, additional, Vallisa, Daniele, additional, Pulsoni, Alessandro, additional, Bonomini, Luisella, additional, Bertoni, Francesco, additional, Dolcetti, Riccardo, additional, Zucca, Emanuele, additional, and Ponzoni, Maurilio, additional

Published
2022
Full Text
View/download PDF

14. Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study

Author

Luminari, S, Manni, M, Galimberti, S, Versari, A, Tucci, A, Boccomini, C, Farina, L, Olivieri, J, Marcheselli, L, Guerra, L, Ferrero, S, Arcaini, L, Cavallo, F, Kovalchuk, S, Skrypets, T, Del Giudice, I, Chauvie, S, Patti, C, Stelitano, C, Ricci, F, Pinto, A, Margiotta Casaluci, G, Zilioli, V, Merli, A, Ladetto, M, Bolis, S, Pavone, V, Chiarenza, A, Arcari, A, Anastasia, A, Dondi, A, Mannina, D, Federico, M, Luminari, Stefano, Manni, Martina, Galimberti, Sara, Versari, Annibale, Tucci, Alessandra, Boccomini, Carola, Farina, Lucia, Olivieri, Jacopo, Marcheselli, Luigi, Guerra, Luca, Ferrero, Simone, Arcaini, Luca, Cavallo, Federica, Kovalchuk, Sofya, Skrypets, Tetiana, Del Giudice, Ilaria, Chauvie, Stephane, Patti, Caterina, Stelitano, Caterina, Ricci, Francesca, Pinto, Antonello, Margiotta Casaluci, Gloria, Zilioli, Vittorio R, Merli, Anna, Ladetto, Marco, Bolis, Silvia, Pavone, Vincenzo, Chiarenza, Annalisa, Arcari, Annalisa, Anastasia, Antonella, Dondi, Alessandra, Mannina, Donato, Federico, Massimo, Luminari, S, Manni, M, Galimberti, S, Versari, A, Tucci, A, Boccomini, C, Farina, L, Olivieri, J, Marcheselli, L, Guerra, L, Ferrero, S, Arcaini, L, Cavallo, F, Kovalchuk, S, Skrypets, T, Del Giudice, I, Chauvie, S, Patti, C, Stelitano, C, Ricci, F, Pinto, A, Margiotta Casaluci, G, Zilioli, V, Merli, A, Ladetto, M, Bolis, S, Pavone, V, Chiarenza, A, Arcari, A, Anastasia, A, Dondi, A, Mannina, D, Federico, M, Luminari, Stefano, Manni, Martina, Galimberti, Sara, Versari, Annibale, Tucci, Alessandra, Boccomini, Carola, Farina, Lucia, Olivieri, Jacopo, Marcheselli, Luigi, Guerra, Luca, Ferrero, Simone, Arcaini, Luca, Cavallo, Federica, Kovalchuk, Sofya, Skrypets, Tetiana, Del Giudice, Ilaria, Chauvie, Stephane, Patti, Caterina, Stelitano, Caterina, Ricci, Francesca, Pinto, Antonello, Margiotta Casaluci, Gloria, Zilioli, Vittorio R, Merli, Anna, Ladetto, Marco, Bolis, Silvia, Pavone, Vincenzo, Chiarenza, Annalisa, Arcari, Annalisa, Anastasia, Antonella, Dondi, Alessandra, Mannina, Donato, and Federico, Massimo

Abstract

PURPOSE We compared 2 years of rituximab maintenance (RM) with a response-adapted postinduction approach in patients with follicular lymphoma who responded to induction immunochemotherapy. METHODS We randomly assigned treatment-naive, advanced-stage, high-tumor burden follicular lymphoma patients to receive standard RM or a response-adapted postinduction approach on the basis of metabolic response and molecular assessment of minimal residual disease (MRD). The experimental arm used three types of postinduction therapies: for complete metabolic response (CMR) and MRD-negative patients, observation; for CMR and MRD-positive (end of induction or follow-up) patients, four doses of rituximab (one per week, maximum three courses) until MRD-negative; and for non-CMR patients, one dose of ibritumomab tiuxetan followed by standard RM. The study was designed as noninferiority trial with progression-free survival (PFS) as the primary end point. RESULTS Overall, 807 patients were randomly assigned. After a median follow-up of 53 months (range, 1-92 months), patients in the standard arm had a significantly better PFS than those in the experimental arm (3-year PFS 86% v 72%; P < .001). The better PFS of the standard versus experimental arm was confirmed in all the study subgroups except non-CMR patients (n =65; P = .274). The 3-year overall survival was 98% (95% CI, 96 to 99) and 97% (95% CI, 95 to 99) in the reference and experimental arms, respectively (P = .238). CONCLUSION A metabolic and molecular response-adapted therapy as assessed in the FOLL12 study was associated with significantly inferior PFS compared with 2-year RM. The better efficacy of standard RM was confirmed in the subgroup analysis and particularly for patients achieving both CMR and MRDnegative.

Published
2022

15. Outcome of follicular lymphoma (FL) patients in maintenance with antiCD20 monoclonal antibodies (MoAb) in SARS-Cov2 era.

Author

Castellino, Alessia, primary, Castellino, Claudia, additional, Boccomini, Carola, additional, Clerico, Michele, additional, Nicoli, Paolo, additional, Vanazzi, Anna, additional, Fanelli, Fulvia, additional, Perrone, Tommasina, additional, Marchesi, Francesco, additional, Cocito, Federica, additional, Merli, Michele, additional, Bigliardi, Sara, additional, Mecacci, Bianca, additional, Bozzoli, Valentina, additional, Margiotta-Casaluci, Gloria, additional, Meli, Erika, additional, Anastasia, Antonella, additional, Farina, Lucia, additional, Annibali, Ombretta, additional, and Massaia, Massimo, additional

Published
2022
Full Text
View/download PDF

16. Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Author

Tiacci, Enrico, Park, Jae H., De Carolis, Luca, Chung, Stephen S., Broccoli, Alessandro, Scott, Sasinya, Zaja, Francesco, Devlin, Sean, Pulsoni, Alessandro, Chung, Young R., Cimminiello, Michele, Kim, Eunhee, Rossi, Davide, Stone, Richard M., Motta, Giovanna, Saven, Alan, Varettoni, Marzia, Altman, Jessica K., Anastasia, Antonella, Grever, Michael R., Ambrosetti, Achille, Rai, Kanti R., Fraticelli, Vincenzo, Lacouture, Mario E., Carella, Angelo M., Levine, Ross L., Leoni, Pietro, Rambaldi, Alessandro, Falzetti, Franca, Ascani, Stefano, Capponi, Monia, Martelli, Maria P., Park, Christopher Y., Pileri, Stefano A., Rosen, Neal, Foà, Robin, Berger, Michael F., Zinzani, Pier L., Abdel-Wahab, Omar, Falini, Brunangelo, and Tallman, Martin S.

Published
2015
Full Text
View/download PDF

20. Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

Author

Merli, Michele, Anastasia, Antonella, Deodato, Marina, Nassi, Luca, Cavalloni, Chiara, Franceschetti, Silvia, Gentile, Massimo, Arcari, Annalisa, Sartori, Roberto, Cencini, Emanuele, Loseto, Giacomo, Vitale, Candida, Catania, Gioacchino, Annibali, Ombretta, Nasso, Daniela, Cocito, Federica, Ferrarini, Isacco, Finotto, Silvia, Noto, Alessandro, Bianchi, Benedetta, Ferrario, Andrea, Motta, Marina, Rattotti, Sara, Frustaci, Annamaria, Passamonti, Francesco, and Arcaini, Luca

Published
2023
Full Text
View/download PDF

21. Deciphering the Immune Microenvironment in Waldenstrom's Macroglobulinemia

Author

Sacco, Antonio, Desantis, Vanessa, Celay, Jon, Giustini, Viviana, Rigali, Fabio, Savino, Francesco, Cea, Michele, Soncini, Debora, Cagnetta, Antonia, Solimando, Antonio Giovanni, D'Aliberti, Deborah, Spinelli, Silvia, Ramazzotti, Daniele, Almici, Camillo, Todoerti, Katia, Neri, Antonino, Anastasia, Antonella, Tucci, Alessandra, Motta, Marina, Chiarini, Marco, Kawano, Yawara, Martinez-Climent, Jose A, Piazza, Rocco, and Roccaro, Aldo

Published
2023
Full Text
View/download PDF

22. Early-Stage Follicular Lymphoma: Learnings from the Final Analysis of the Multicenter Phase II FIL (Fondazione Italiana Linfomi) “Miro” Trial, Combining Local Radiotherapy and MRD-Driven Immunotherapy

Author

Pulsoni, Alessandro, Tosti, Maria Elena, Ferrero, Simone, Luminari, Stefano, Dondi, Alessandra, Liberati, Anna Marina, Cenfra, Natalia, Renzi, Daniela, Zanni, Manuela, Boccomini, Carola, Ferreri, Andrés José María, Rattotti, Sara, Zilioli, Vittorio Ruggero, Bernuzzi, Patrizia, Bolis, Silvia, Musuraca, Gerardo, Nassi, Luca, Perrone, Tommasina, Stelitano, Caterina, Anastasia, Antonella, Corradini, Paolo, Partesotti, Giovanni, Re, Francesca, Cencini, Emanuele, Mannarella, Clara, Mannina, Donato, Molinari, Anna Lia, Tani, Monica, Annechini, Giorgia, Assanto, Giovanni Manfredi, Grapulin, Lavinia, Guarini, Anna, Cavalli, Marzia, De Novi, Lucia Anna, Bomben, Riccardo, Ciabatti, Elena, Mantoan, Barbara, Drandi, Daniela, Della Starza, Irene, Arcaini, Luca, Ricardi, Umberto, Gattei, Valter, Galimberti, Sara, Ladetto, Marco, Foà, Robin, and Del Giudice, Ilaria

Published
2023
Full Text
View/download PDF

23. Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Author

Boccomini, Carola, Botto, Barbara, Evangelista, Andrea, Zilioli, Vittorio Ruggero, Anastasia, Antonella, Cavallo, Federica, Merli, Francesco, Zanni, Manuela, Tani, Monica, Chiarenza, Annalisa, Liberati, Anna Marina, Conconi, Annarita, Corradini, Paolo, Bari, Alessia, Annechini, Giorgia, Gaidano, Gianluca, Spina, Michele, Sartori, Roberto, Castellino, Claudia, Puccini, Benedetta, Arcari, Annalisa, Bigliardi, Sara, Matta, Giorgia, Merli, Michele, Mannina, Donato, Marino, Dario, Galieni, Piero, Ciambelli, Fabrizio, Musuraca, Gerardo, Bottelli, Chiara, Muzi, Cristina, Ferrero, Simone, Luminari, Stefano, Ladetto, Marco, Ciccone, Giovannino, and Vitolo, Umberto

Published
2023
Full Text
View/download PDF

24. FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88

Author

Sacco, Antonio, primary, Federico, Cinzia, additional, Giacomini, Arianna, additional, Caprio, Cinzia, additional, Maccarinelli, Federica, additional, Todoerti, Katia, additional, Favasuli, Vanessa, additional, Anastasia, Antonella, additional, Motta, Marina, additional, Rossi, Giuseppe, additional, Bozza, Nicole, additional, Castelli, Riccardo, additional, Neri, Antonino, additional, Ronca, Roberto, additional, Cattaneo, Chiara, additional, Tucci, Alessandra, additional, Mor, Marco, additional, Presta, Marco, additional, and Roccaro, Aldo M., additional

Published
2020
Full Text
View/download PDF

25. Multicenter Long Term Follow-up in Hairy Cell Leukemia Patients Treated with Cladribine: A Thirty-Year Experience

Author

Criscuolo, Marianna, primary, Broccoli, Alessandro, additional, Galli, Eugenio, additional, Piciocchi, Alfonso, additional, Maraglino, Alessio, additional, Anastasia, Antonella, additional, Annibali, Ombretta, additional, Cantonetti, Maria, additional, De Luca, Maria Lucia, additional, Fianchi, Luana, additional, Frustaci, Annamaria, additional, Galli, Elettra, additional, Guarnera, Luca, additional, Kovalchuk, Sofia, additional, Marchesi, Francesco, additional, Motta, Marina, additional, Nizzoli, Maria Elena, additional, Offidani, Massimo, additional, Orsucci, Lorella, additional, Spolzino, Angelica, additional, Stelitano, Caterina, additional, Storti, Sergio, additional, Tedeschi, Alessandra, additional, Trentin, Livio, additional, Varettoni, Marzia, additional, Visentin, Andrea, additional, Volpetti, Stefano, additional, Falini, Brunangelo, additional, Pulsoni, Alessandro, additional, Tiacci, Enrico, additional, Zinzani, Pier Luigi, additional, and Pagano, Livio, additional

Published
2020
Full Text
View/download PDF

26. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19

Author

Cattaneo, Chiara, primary, Daffini, Rosa, additional, Pagani, Chiara, additional, Salvetti, Massimo, additional, Mancini, Valentina, additional, Borlenghi, Erika, additional, D’Adda, Mariella, additional, Oberti, Margherita, additional, Paini, Anna, additional, De Ciuceis, Carolina, additional, Barbullushi, Kordelia, additional, Cancelli, Valeria, additional, Belotti, Angelo, additional, Re, Alessandro, additional, Motta, Marina, additional, Peli, Annalisa, additional, Bianchetti, Nicola, additional, Anastasia, Antonella, additional, Dalceggio, Daniela, additional, Roccaro, Aldo M., additional, Tucci, Alessandra, additional, Cairoli, Roberto, additional, Muiesan, Maria Lorenza, additional, and Rossi, Giuseppe, additional

Published
2020
Full Text
View/download PDF

27. Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy

Author

Castagna, Luca, Bramanti, Stefania, Balzarotti, Monica, Sarina, Barbara, Todisco, Elisabetta, Anastasia, Antonella, Magagnoli, Massimo, Mazza, Rita, Nozza, Andrea, Giordano, Laura, Rodari, Marcello, Rinifilo, Eva, Chiti, Arturo, and Santoro, Armando

Published
2009
Full Text
View/download PDF

30. Overcoming the Supportive Stroma-Induced Proliferation in Waldenstrom's Macroglobulinemia By Selective Inhibition of the FGF/FGF-Receptor Axis

Author

Federico, Cinzia, primary, Sacco, Antonio, additional, Todoerti, Katia, additional, Giacomini, Arianna, additional, Ghedini, Gaia C, additional, Lanzi, Gaetana, additional, Motta, Marina, additional, Anastasia, Antonella, additional, Favasuli, Vanessa, additional, Ronca, Roberto, additional, Giliani, Silvia, additional, Bozza, Nicole, additional, Castelli, Riccardo, additional, Rossi, Giuseppe, additional, Neri, Antonino, additional, Mor, Marco, additional, Presta, Marco, additional, and Roccaro, Aldo M., additional

Published
2019
Full Text
View/download PDF

31. Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells

Author

Rodríguez, Sara, primary, Botta, Cirino, additional, Celay, Jon, additional, Goicoechea, Ibai, additional, Garcia-Barchino, Maria J, additional, Valdés-Mas, Rafael, additional, Carrasco, Yolanda, additional, Alameda, Daniel, additional, Garcés, Juan José, additional, Larrayoz, Marta, additional, Santos, Susana, additional, Alignani, Diego, additional, Vilas-Zornoza, Amaia, additional, Lorenzo-Vivas, Erika, additional, Pérez Ruiz, Cristina, additional, Garate, Sonia, additional, Sarai, Sarvide, additional, Gascue, Amaia, additional, Reinhardt, Christian, additional, Sanchez-Garcia, Isidro, additional, Larrayoz, Maria Jose, additional, Calasanz, Maria Jose, additional, Prosper, Felipe, additional, Motta, Marina, additional, Anastasia, Antonella, additional, Sacco, Antonio, additional, Gentile, Massimo, additional, Duarte, Sara, additional, Vitoria, Helena, additional, Geraldes, Catarina, additional, Paiva, Artur, additional, Roccaro, Aldo M., additional, San-Miguel, Jesús, additional, Martinez-Climent, Jose Angel, additional, and Paiva, Bruno, additional

Published
2019
Full Text
View/download PDF

32. EARLY STAGE Follicular Lymphoma: First Results of the FIL "Miro" Study, a Multicenter Phase II Trial Combining Local Radiotherapy and MRD-Driven Immunotherapy

Author

Pulsoni, Alessandro, primary, Tosti, Maria Elena, primary, Ferrero, Simone, primary, Luminari, Stefano, primary, Liberati, Anna Marina, primary, Cenfra, Natalia, primary, Renzi, Daniela, primary, Zanni, Emanuela, primary, Boccomini, Carola, primary, Ferreri, Andres JM, primary, Rattotti, Sara, primary, Zilioli, Vittorio Ruggero, primary, Bernuzzi, Patrizia, primary, Bolis, Silvia, primary, Musuraca, Gerardo, primary, Nassi, Luca, primary, Perrone, Tommasina, primary, Stelitano, Caterina, primary, Anastasia, Antonella, primary, Corradini, Paolo, primary, Partesotti, Giovanni, primary, Re, Francesca, primary, Cencini, Emanuele, primary, Mannarella, Clara, primary, Mannina, Donato, primary, Molinari, Anna Lia, primary, Tani, Monica, primary, Annechini, Giorgia, primary, Assanto, Giovanni Manfredi, primary, Grapulin, Lavinia, primary, Della Starza, Irene, primary, Cavalli, Marzia, primary, De Novi, Lucia Anna, primary, Ciabatti, Elena, primary, Mantoan, Barbara, primary, Guarini, Anna, primary, Arcaini, Luca, primary, Ricardi, Umberto, primary, Gattei, Valter, primary, Galimberti, Sara, primary, Ladetto, Marco, primary, Del Giudice, Ilaria, primary, and Foà, Robin, primary

Published
2019
Full Text
View/download PDF

33. Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Author

Santoro, Armando, primary, Mazza, Rita, additional, Pulsoni, Alessandro, additional, Re, Alessandro, additional, Bonfichi, Maurizio, additional, Zilioli, Vittorio Ruggero, additional, Salvi, Flavia, additional, Anastasia, Antonella, additional, Luminari, Stefano, additional, Gotti, Manuel, additional, Peli, Annalisa, additional, Liberati, Anna Marina, additional, Di Renzo, Nicola, additional, Castagna, Luca, additional, Giordano, Laura, additional, and Carlo-Stella, Carmelo, additional

Published
2018
Full Text
View/download PDF

35. Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).

Author

Rusconi, Chiara, Anastasia, Antonella, Chiarenza, Annalisa, Marcheselli, Luigi, Cavallo, Federica, Rattotti, Sara, Botto, Barbara, Ferrari, Angela, Nassi, Luca, Pagani, Chiara, Meli, Erika, Arcaini, Luca, Federico, Massimo, and Rossi, Giuseppe

Subjects
*LYMPHOMAS, *PROGRESSION-free survival, *THERAPEUTICS
Abstract

Summary: Optimal treatment for transformed follicular lymphoma (tFL) is not fully defined. Clinical characteristics and treatments that impact on post‐transformation outcome of 176 biopsy‐proven tFL were analysed. Transformation occurred at initial diagnosis in 52% (Group 1) and after a FL diagnosis in 48% (Group 2). Five‐year overall survival was 84% for Group 1 and 51% for Group 2 (P < 0·001). In Group 1, 5‐year progression‐free survival was superior after rituximab maintenance compared to observation only (94% vs. 53%, P = 0·024). In Group 2, an inverse trend was found between survival and both a higher number of pre‐transformation treatment lines and a short time‐to‐transformation. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

36. The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions

Author

Sacco, Antonio, primary, Fenotti, Adriano, additional, Affò, Loredana, additional, Bazzana, Stefano, additional, Russo, Domenico, additional, Presta, Marco, additional, Malagola, Michele, additional, Anastasia, Antonella, additional, Motta, Marina, additional, Patterson, Christopher J., additional, Rossi, Giuseppe, additional, Imberti, Luisa, additional, Treon, Steven P., additional, Ghobrial, Irene M., additional, and Roccaro, Aldo M., additional

Published
2017
Full Text
View/download PDF

38. Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study

Author

Santoro, Armando, primary, Mazza, Rita, additional, Pulsoni, Alessandro, additional, Re, Alessandro, additional, Bonfichi, Maurizio, additional, Zilioli, Vittorio Ruggero, additional, Salvi, Flavia, additional, Merli, Francesco, additional, Anastasia, Antonella, additional, Luminari, Stefano, additional, Annechini, Giorgia, additional, Gotti, Manuel, additional, Peli, Annalisa, additional, Liberati, Anna Marina, additional, Di Renzo, Nicola, additional, Castagna, Luca, additional, Giordano, Laura, additional, and Carlo-Stella, Carmelo, additional

Published
2016
Full Text
View/download PDF

39. Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study

Author

Zinzani, Pier Luigi, primary, Broccoli, Alessandro, additional, Gioia, Daniela Maria, additional, Castagnoli, Antonio, additional, Ciccone, Giovannino, additional, Evangelista, Andrea, additional, Santoro, Armando, additional, Ricardi, Umberto, additional, Bonfichi, Maurizio, additional, Brusamolino, Ercole, additional, Rossi, Giuseppe, additional, Anastasia, Antonella, additional, Zaja, Francesco, additional, Vitolo, Umberto, additional, Pavone, Vincenzo, additional, Pulsoni, Alessandro, additional, Rigacci, Luigi, additional, Gaidano, Gianluca, additional, Stelitano, Caterina, additional, Salvi, Flavia, additional, Rusconi, Chiara, additional, Tani, Monica, additional, Freilone, Roberto, additional, Pregno, Patrizia, additional, Borsatti, Eugenio, additional, Sacchetti, Gian Mauro, additional, Argnani, Lisa, additional, and Levis, Alessandro, additional

Published
2016
Full Text
View/download PDF

40. B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)

Author

Balzarotti, Monica, primary, Brusamolino, Ercole, additional, Angelucci, Emanuele, additional, Carella, Angelo Michele, additional, Vitolo, Umberto, additional, Russo, Eleonora, additional, Congiu, Angelagiovanna, additional, Gotti, Manuel, additional, Massidda, Stefania, additional, Botto, Barbara, additional, Annechini, Giorgia, additional, Spina, Michele, additional, Re, Alessandro, additional, Zilioli, Vittorio Ruggero, additional, Merli, Francesco, additional, Salvi, Flavia, additional, Stelitano, Caterina, additional, Bonfichi, Maurizio, additional, Rodari, Marcello, additional, Murru, Roberta, additional, Magagnoli, Massimo, additional, Anastasia, Antonella, additional, Mazza, Rita, additional, Giordano, Laura, additional, and Santoro, Armando, additional

Published
2016
Full Text
View/download PDF

41. Management of Grade 3B Follicular Lymphoma (FL) Outside Clinical Trials: A Multicentric Retrospective Analysis on Behalf of Fondazione Italiana Linfomi (FIL)

Author

Botto, Barbara, primary, Cavallo, Federica, additional, Zanni, Manuela, additional, Anastasia, Antonella, additional, Rusconi, Chiara, additional, Chiarenza, Annalisa, additional, Ferrari, Angela, additional, Rattotti, Sara, additional, Dondi, Alessandra, additional, Calabrese, Marco, additional, Evangelista, Andrea, additional, Vitolo, Umberto, additional, Federico, Massimo, additional, and Rossi, Giuseppe, additional

Published
2015
Full Text
View/download PDF

42. Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Author

Santoro, Armando, primary, Mazza, Rita, additional, Pulsoni, Alessandro, additional, Re, Alessandro, additional, Bonfichi, Maurizio, additional, Zilioli, Vittorio Ruggero, additional, Salvi, Flavia, additional, Anastasia, Antonella, additional, Luminari, Stefano, additional, Gotti, Manuel, additional, Peli, Annalisa, additional, Liberati, Anna Marina, additional, Di Renzo, Nicola, additional, Castagna, Luca, additional, Giordano, Laura, additional, and Carlo-Stella, Carmelo, additional

Published
2015
Full Text
View/download PDF

43. Outcome of Transformed FL(t-FL) Worsens According to the Timing of Transformation and to the Number of Previous Therapies. A Survey of the Fondazione Italiana Linfomi (FIL)

Author

Rusconi, Chiara, primary, Anastasia, Antonella, additional, Chiarenza, Annalisa, additional, Marcheselli, Luigi, additional, Cavallo, Federica, additional, Rattotti, Sara, additional, Botto, Barbara, additional, Ferrari, Angela, additional, Zanni, Manuela, additional, Calabrese, Marco, additional, Pagani, Chiara, additional, Meli, Erika, additional, Federico, Massimo, additional, and Rossi, Giuseppe, additional

Published
2015
Full Text
View/download PDF

44. Immunological Derangement in Follicular Lymphoma Patients Developing Severe Side Effects during Treatment with PI3K Inhibitors

Author

Motta, Marina, primary, Chiarini, Marco, additional, Petullà, Marta, additional, Ghidini, Claudia, additional, Vaglio Tessitore, Marion, additional, Giustini, Viviana, additional, Pagani, Chiara, additional, Anastasia, Antonella, additional, Ferrari, Samantha, additional, Tucci, Alessandra, additional, Imberti, Luisa, additional, and Rossi, Giuseppe, additional

Published
2015
Full Text
View/download PDF

48. Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Author

Tiacci, Enrico, primary, De Carolis, Luca, additional, Zinzani, Pier Luigi, additional, Pulsoni, Alessandro, additional, Zaja, Francesco, additional, Cimminiello, Michele, additional, Ambrosetti, Achille, additional, Rossi, Davide, additional, Motta, Giovanna, additional, Varettoni, Marzia, additional, Fraticelli, Vincenzo, additional, Carella, Angelo Michele, additional, Anastasia, Antonella, additional, Leoni, Pietro, additional, Rambaldi, Alessandro, additional, Pileri, Stefano Aldo, additional, Foà, Robin, additional, and Falini, Brunangelo, additional

Published
2014
Full Text
View/download PDF

49. A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Author

Montillo, Marco, primary, Rossi, Davide, additional, Motta, Marina, additional, Quaresmini, Giulia, additional, Rossi, Marianna, additional, Coscia, Marta, additional, Anastasia, Antonella, additional, Rossini, Fausto, additional, Cortelezzi, Agostino, additional, Nador, Guido, additional, Scarfò, Lydia, additional, Cairoli, Roberto, additional, Ceggio, Daniela Dal, additional, De Paoli, Lorenzo, additional, Morra, Enrica, additional, Rambaldi, Alessandro, additional, Orlandi, Ester, additional, Massaia, Massimo, additional, and Tedeschi, Alessandra, additional

Published
2013
Full Text
View/download PDF

50. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.

Author

Pata, Giacomo, Damiani, Enrico, Bartoli, Michele, Solari, Stefano, Anastasia, Antonella, Pagani, Chiara, Tucci, Alessandra, and Ragni, Fulvio

Subjects
SPLENECTOMY, LYMPHOMAS, HEMATOLOGY, UNIVARIATE analysis, SPLEEN, PNEUMONIA, PLEURAL effusions
Abstract

The article focuses on a study related to determination of outcomes of splenectomy therapy for splenic marginal zone lymphoma (SMZL) through splenectomy. Topics discussed include achieving hematologic response by patients after the therapy; revealing postoperative predictive cranio-caudal length and spleen weight through the univariate analysis; and reporting on pleural effusions and pneumonia occurrence in patients.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results